Enovis director granted 770 common shares

Enovis CORP director Christine Ortiz received a stock grant that increased her direct ownership.

Rhea-AI Filing Summary

Enovis CORP director Christine Ortiz received a stock grant that increased her direct ownership. On March 31, 2026, she was granted 770 shares of Enovis common stock at a stated price of $0.00 per share, reflecting a compensation-related award rather than an open-market purchase.

After this grant, Ortiz directly holds 15,665 shares of Enovis common stock. The filing shows no accompanying sales or derivative exercises, so this transaction represents a small, routine increase in her equity stake through non-derivative stock compensation.

Insider Trade Summary

Grant/Award: 770 shares

Grant/Award 1 txn

Insider Ortiz Christine

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common stock, par value $0.001	770	$0.00	$0.00

Holdings After Transaction: Common stock, par value $0.001 — 15,665 shares (Direct)

Key Figures

Shares granted: 770 shares Grant price: $0.00 per share Total shares after grant: 15,665 shares

3 metrics

Shares granted 770 shares Common stock grant on March 31, 2026

Grant price $0.00 per share Reported transaction price for the 770-share award

Total shares after grant 15,665 shares Ortiz direct Enovis common stock holdings following the transaction

Key Terms

grant/award acquisition, non-derivative, Form 4

3 terms

grant/award acquisition financial

"transaction_action: "grant/award acquisition""

non-derivative financial

"transaction_type: "non-derivative""

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Enovis (ENOV) report for Christine Ortiz?

Enovis reported that director Christine Ortiz received a grant of 770 common shares as stock compensation. The shares were recorded at $0.00 per share, indicating an award rather than an open-market purchase.

How many Enovis (ENOV) shares does Christine Ortiz hold after this grant?

Following the latest grant, director Christine Ortiz directly holds 15,665 shares of Enovis common stock. This total reflects the addition of 770 granted shares and shows her current reported equity stake in the company.

Was the Enovis (ENOV) insider transaction a stock purchase or a grant?

The transaction was a grant/award acquisition, not an open-market purchase. Ortiz received 770 common shares at a stated price of $0.00, which is typical for director or executive equity compensation awards.

Did Christine Ortiz sell any Enovis (ENOV) shares in this Form 4 filing?

No sales were reported in this Form 4. The filing shows only a single acquisition of 770 common shares through a grant, with no corresponding sale, tax withholding, or derivative exercise transactions disclosed.

What type of security did Enovis (ENOV) grant to director Christine Ortiz?

Ortiz received common stock of Enovis CORP with a par value of $0.001 per share. The reported transaction involved 770 non-derivative common shares, directly increasing her share ownership without any listed exercise or expiration terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 09:00 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ortiz Christine

(Last) (First) (Middle)

2711 CENTERVILLE ROAD

SUITE 400

(Street)

WILMINGTON DELAWARE 19808

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Enovis CORP [ ENOV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, par value $0.001	03/31/2026		A		770	A	$0.00	15,665	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Brian P. Hanigan, attorney-in-fact	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)